Ethyl 3,4-dihydroxybenzoate (EDHB) is a small molecule antioxidant, which inhibits PHD activity, stabilizes HIF-1α, and promotes angiogenesis by upregulating VEGF, thus preventing steroid-induced osteonecrosis of the femoral head [18,111]. Here, HIF1A is linked to osteonecrosis.